Emergent Health Corp
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxyg… Read more
Market Cap & Net Worth: Emergent Health Corp (EMGE)
Emergent Health Corp (PINK:EMGE) has a market capitalization of $426.95K ($426.95K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50780 globally and #15545 in its home market, demonstrating a 11.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Emergent Health Corp's stock price $0.00 by its total outstanding shares 426951112 (426.95 Million).
Emergent Health Corp Market Cap History: 2015 to 2025
Emergent Health Corp's market capitalization history from 2015 to 2025. Data shows change from $26.04 Million to $426.95K (-37.07% CAGR).
Emergent Health Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Emergent Health Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.18x
Emergent Health Corp's market cap is 0.18 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $38.43 Million | $183.12K | -$67.50K | 209.84x | N/A |
| 2020 | $30.36 Million | $167.19K | -$79.12K | 181.57x | N/A |
| 2021 | $23.91 Million | $119.57K | -$288.76K | 199.97x | N/A |
| 2022 | $1.71 Million | $574.61K | -$2.11 Million | 2.97x | N/A |
| 2023 | $298.87K | $1.64 Million | -$1.63 Million | 0.18x | N/A |
Competitor Companies of EMGE by Market Capitalization
Companies near Emergent Health Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Emergent Health Corp by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Emergent Health Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Emergent Health Corp's market cap moved from $26.04 Million to $ 426.95K, with a yearly change of -37.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $426.95K | 0.00% |
| 2024 | $426.95K | +42.86% |
| 2023 | $298.87K | -82.50% |
| 2022 | $1.71 Million | -92.86% |
| 2021 | $23.91 Million | -21.24% |
| 2020 | $30.36 Million | -21.00% |
| 2019 | $38.43 Million | +116.87% |
| 2018 | $17.72 Million | +315.00% |
| 2017 | $4.27 Million | -88.24% |
| 2016 | $36.29 Million | +39.34% |
| 2015 | $26.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Emergent Health Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $426.95K USD |
| MoneyControl | $426.95K USD |
| MarketWatch | $426.95K USD |
| marketcap.company | $426.95K USD |
| Reuters | $426.95K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.